Medicine is moving toward a future where AI simulations can predict disease risks and test treatments before they ever reach real patients. As health systems collect more data from wearables, scans, biomarkers and medical records, the biggest challenge becomes modeling biology at massive scale rather than simply gathering more information. Virtual clinical trials may first support traditional trials, then eventually reshape drug development, especially in cancer and rare diseases. Future medical breakthroughs may come less from testing directly in people and more from building accurate “mirrors” of human biology to experiment safely inside.